Definitive Contract 75F40119C10013
- Not listed
- This is a federal contract award from the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for $95,672.40 to provide genetic analyzer corrective/remedial repair and preventive maintenance services. The contract has a period of performance through February 9, 2022 and is a firm fixed price purchase order. There is no set-aside designation. Life Technologies has established itself as a prime contractor across multiple federal...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed-price purchase order to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, for a MICROSEQ GENETIC ANALYZER. The $323,879.64 award does not have a set-aside designation and was made on August 24, 2017 with a completion date of August 23, 2021. As a division of Thermo Fisher Scientific, Life Technologies serves as a prime contractor across various federal...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific Inc. The contract is for the delivery of a genetic analyzer with a 4-year post-warranty maintenance option, with a ceiling value of $80,335.95 and a completion date of September 14, 2025. Life Technologies Corporation is a leading provider of biomedical research and genetic analysis tools and technologies to government agencies and...
- This federal contract award to Life Technologies Corporation, doing business as Thermo Fisher Scientific, is for DNA analysis equipment and services. The $585,136.93 Firm Fixed Price contract was awarded by the Defense Health Agency and has a completion date of January 3, 2025. The contract is a Blanket Purchase Agreement (BPA) call order, indicating it is part of a larger indefinite delivery vehicle. Life Technologies has been awarded multiple federal contracts and grant sub-awards,...
- This is a Firm Fixed Price service contract awarded by the Southeast Area of the U.S. federal agency to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, for a DNA analyzer from January 29, 2017 to January 28, 2018. The contract has a ceiling value of $18,247.08 and was not set aside. Life Technologies is a manufacturer of scientific instruments, reagents, and consumables that provides a wide range of products and services to support federal initiatives related to...
- This federal contract award, CBER-15-C-0140, was issued by the Food and Drug Administration (FDA) to Life Technologies Corporation, doing business as Thermo Fisher Scientific, for the provision of reagent sequencing kits and 24-capillary array sequencing kits. The contract has a ceiling value of $34,510.70 and was awarded on August 20, 2015, with a completion date of September 20, 2015. The contract is a firm fixed-price purchase order and was not set aside for any specific business type. Life...
- This is a federal contract award from the National Human Genome Research Institute, a civilian agency, to Life Technologies Corporation, doing business as Thermo Fisher Scientific. The $3,767.70 fixed-price contract is a Blanket Purchase Agreement (BPA) call with a completion date of February 28, 2017. The contract was not set aside for any specific business type. Life Technologies Corporation is a prominent manufacturer of scientific instruments, reagents, and consumables that provides...
- This federal contract award is for a 3500 Genetic Analyzer provided by Life Technologies Corporation, doing business as Thermo Fisher Scientific, a prominent manufacturer of scientific instruments, reagents, and consumables. The $10,899.16 Firm Fixed Price contract was awarded on May 1, 2012 by the National Eye Institute, a civilian agency, with an ultimate completion date of April 30, 2024. The contract is a Blanket Purchase Agreement (BPA) call, indicating it is part of a larger indefinite...
- This federal contract award was issued by the National Center for Advancing Translational Sciences, a civilian agency within the U.S. Department of Health and Human Services. The $23,619.60 firm fixed-price purchase order was awarded to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific, a leading manufacturer of scientific instruments, reagents, and consumables. The contract supports the delivery of genetic analyzers, reagents, assays, instruments, and associated repair...
- This federal contract award to Life Technologies Corporation, doing business as Thermo Fisher Scientific, provides a SEQSTUDIO GENETIC ANALYZER to the U.S. government. The $40,043.82 firm fixed price delivery order contract was awarded on September 15, 2020 by the Southeast Area of the Department of Defense's civilian agency. The contract does not have a set-aside designation, indicating Life Technologies competed as a prime contractor. Life Technologies is a prominent manufacturer of scientific...
The Department of Health and Human Services Food and Drug Administration awarded a $918,227.19 firm-fixed-price definitive contract to Life Technologies Corporation, now part of Thermo Fisher Scientific Inc., for the provision of genetic analyzers, warranty, and maintenance services. The contract has an April 26, 2024 completion date and was awarded on April 18, 2019 without the use of a set-aside. Life Technologies Corporation, a leading provider of biomedical research and genetic analysis tools, will deliver specialized products and services to support the FDA's research, healthcare, and public health missions. Key items to be provided include genetic analyzers, real-time PCR systems, nucleic acid extraction kits, and TaqMan diagnostic assays. This award is part of the company's existing federal contract vehicles to supply genome sequencing reagents and services to the Department of Veterans Affairs.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
(1) Genetic Analyzer Systems, Thermocyclers, UV Gel Imagers | FDA-19-SOL-1210123 | Department of Health and Human Services Food and Drug Administration | Solicitation 1/1 | 3/13/19, 2:29 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $476.0k | 6/6/19 | |
| Not listed | Not listed | $238.0k | 4/18/19 |